je.st
news
Seattle Genetics' Antibody Drug Conjugate Tech Prominent at ASCO Meeting
2014-06-01 13:32:00| Biotech - Topix.net
Seattle Genetics, the company that pioneered the antibody-drug conjugate platform in Adcetris, the Hodgkin's lymphoma treatment, has data presented from a handful of collaborator programs at the American Society of Clinical Oncology's 50th Annual Meeting being held May 30 to June 3, 2014 in Chicago, IL.
Tags: tech
meeting
drug
seattle
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||